Scientists at Stanford University have found in the blood of 22 newborns and 12 adults antibodies to the two most important types of Cas9, the protein involved in the CRISPR technology of gene editing. Immune responses can “hinder the safe and effective use” of CRISPR to treat diseases and “may even result in significant toxicity”.

See original (not translated) news ➥

 

See translated news ➥